BRUSSELS, Sept 18 (Reuters) - Belgian pharmaceutical group Janssen Pharmaceutica, part of U.S. healthcare giant Johnson & Johnson (JNJ.N: Quote, Profile, Research), will dismiss 688 workers as part of a restructuring programme announced on Tuesday, a spokesman said.
